Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation

Mads Thomassen; Torben A Kruse; Karen Ege Olsen; A Borg; Anne Marie Gerdes

doi:10.1007/s10549-004-9503-3

Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation

Mads Thomassen, Torben A Kruse, Karen Ege Olsen, A Borg, Anne Marie Gerdes

2 Citations (Scopus)

Abstract

We have examined a family with a germline BRCA2 mutation in three cases of invasive breast cancer and one case of ductal carcinoma in situ (DCIS). Loss of heterozygosity (LOH) has been demonstrated at the BRCA2 locus in all cases. This result may suggest that the germline mutation in BRCA2 is the initiating step of DCIS and support the theory that DCIS is a precursor of invasive breast carcinoma in hereditary breast cancer.

Original language	English
Journal	Breast Cancer Research and Treatment
Volume	87
Issue number	3
Pages (from-to)	273-6
Number of pages	4
ISSN	0167-6806
DOIs	https://doi.org/10.1007/s10549-004-9503-3
Publication status	Published - Oct 2004
Externally published	Yes

Keywords

Adult
Breast Neoplasms/genetics
Carcinoma, Intraductal, Noninfiltrating/genetics
Female
Genes, BRCA2
Genetic Predisposition to Disease
Humans
Loss of Heterozygosity
Male
Mutation
Pedigree

Access to Document

10.1007/s10549-004-9503-3

Cite this

@article{c677f6c99d4944eb8f3e6a5dd3782a02,

title = "Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation",

abstract = "We have examined a family with a germline BRCA2 mutation in three cases of invasive breast cancer and one case of ductal carcinoma in situ (DCIS). Loss of heterozygosity (LOH) has been demonstrated at the BRCA2 locus in all cases. This result may suggest that the germline mutation in BRCA2 is the initiating step of DCIS and support the theory that DCIS is a precursor of invasive breast carcinoma in hereditary breast cancer.",

keywords = "Adult, Breast Neoplasms/genetics, Carcinoma, Intraductal, Noninfiltrating/genetics, Female, Genes, BRCA2, Genetic Predisposition to Disease, Humans, Loss of Heterozygosity, Male, Mutation, Pedigree",

author = "Mads Thomassen and Kruse, \{Torben A\} and Olsen, \{Karen Ege\} and A Borg and Gerdes, \{Anne Marie\}",

year = "2004",

month = oct,

doi = "10.1007/s10549-004-9503-3",

language = "English",

volume = "87",

pages = "273--6",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation

AU - Thomassen, Mads

AU - Kruse, Torben A

AU - Olsen, Karen Ege

AU - Borg, A

AU - Gerdes, Anne Marie

PY - 2004/10

Y1 - 2004/10

N2 - We have examined a family with a germline BRCA2 mutation in three cases of invasive breast cancer and one case of ductal carcinoma in situ (DCIS). Loss of heterozygosity (LOH) has been demonstrated at the BRCA2 locus in all cases. This result may suggest that the germline mutation in BRCA2 is the initiating step of DCIS and support the theory that DCIS is a precursor of invasive breast carcinoma in hereditary breast cancer.

AB - We have examined a family with a germline BRCA2 mutation in three cases of invasive breast cancer and one case of ductal carcinoma in situ (DCIS). Loss of heterozygosity (LOH) has been demonstrated at the BRCA2 locus in all cases. This result may suggest that the germline mutation in BRCA2 is the initiating step of DCIS and support the theory that DCIS is a precursor of invasive breast carcinoma in hereditary breast cancer.

KW - Adult

KW - Breast Neoplasms/genetics

KW - Carcinoma, Intraductal, Noninfiltrating/genetics

KW - Female

KW - Genes, BRCA2

KW - Genetic Predisposition to Disease

KW - Humans

KW - Loss of Heterozygosity

KW - Male

KW - Mutation

KW - Pedigree

UR - https://www.scopus.com/pages/publications/8644285489

U2 - 10.1007/s10549-004-9503-3

DO - 10.1007/s10549-004-9503-3

M3 - Journal article

C2 - 15528970

SN - 0167-6806

VL - 87

SP - 273

EP - 276

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 3

ER -

Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this